Imperial College London

ProfessorHolgerAuner

Faculty of MedicineDepartment of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

holger.auner04 Website

 
 
//

Assistant

 

Miss Mandy Sale +44 (0)20 3313 4017

 
//

Location

 

4N7ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Brown:2019:10.1182/blood-2019-123672,
author = {Brown, SR and Hall, A and Kendall, J and Ingleson, E and Flanagan, L and Auner, HW and Boyd, K and Garg, M and Kaiser, MF},
doi = {10.1182/blood-2019-123672},
publisher = {AMER SOC HEMATOLOGY},
title = {Muktwelve: A Randomized Phase II Trial of Selinexor, Cyclophosphamide and Prednisolone Vs Cyclophosphamide and Prednisolone in Relapsed or Refractory Multiple Myeloma (RRMM) Patients},
url = {http://dx.doi.org/10.1182/blood-2019-123672},
year = {2019}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Brown,SR
AU - Hall,A
AU - Kendall,J
AU - Ingleson,E
AU - Flanagan,L
AU - Auner,HW
AU - Boyd,K
AU - Garg,M
AU - Kaiser,MF
DO - 10.1182/blood-2019-123672
PB - AMER SOC HEMATOLOGY
PY - 2019///
SN - 0006-4971
TI - Muktwelve: A Randomized Phase II Trial of Selinexor, Cyclophosphamide and Prednisolone Vs Cyclophosphamide and Prednisolone in Relapsed or Refractory Multiple Myeloma (RRMM) Patients
UR - http://dx.doi.org/10.1182/blood-2019-123672
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577164606270&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -